Hartford Investment Management Co (HIMCO)’s GSK GSK Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,189	Closed	-$551K	–	502
2023 Q3	$551K	Sell	15,189 -1,230	-7%	-$43.7K	0.02%	475
2023 Q2	$585K	Buy	16,419 +2,770	+20%	+$99.4K	0.02%	479
2023 Q1	$486K	Hold	13,649	–	–	0.02%	495
2022 Q4	$480K	Sell	13,649 -177	-1%	-$5.9K	0.01%	508
2022 Q3	$407K	Buy	13,826 +4,028	+41%	+$153K	0.01%	523
2022 Q2	$533K	Sell	9,798 -1,216	-11%	-$67.1K	0.02%	501
2022 Q1	$600K	Hold	11,014	–	–	0.02%	505
2021 Q4	$607K	Hold	11,014	–	–	0.01%	507
2021 Q3	$526K	Hold	11,014	–	–	0.01%	513
2021 Q2	$548K	Buy	11,014 +3,738	+51%	+$180K	0.01%	509
2021 Q1	$325K	Hold	7,276	–	–	0.01%	526
2020 Q4	$335K	Hold	7,276	–	–	0.01%	517
2020 Q3	$342K	Hold	7,276	–	–	0.01%	507
2020 Q2	$371K	Buy	7,276 +1,875	+35%	+$96.2K	0.01%	498
2020 Q1	$256K	Hold	5,401	–	–	0.01%	527
2019 Q4	$317K	Hold	5,401	–	–	0.01%	537
2019 Q3	$288K	Hold	5,401	–	–	0.01%	540
2019 Q2	$270K	Hold	5,401	–	–	0.01%	521
2019 Q1	$282K	Buy	5,401 +417	+8%	+$20.8K	0.01%	518
2018 Q4	$238K	Hold	4,984	–	–	0.01%	621
2018 Q3	$250K	Hold	4,984	–	–	0.01%	667
2018 Q2	$251K	Hold	4,984	–	–	0.01%	679
2018 Q1	$243K	Hold	4,984	–	–	﹤0.01%	560
2017 Q4	$221K	Hold	4,984	–	–	﹤0.01%	564
2017 Q3	$253K	Buy	4,984 +880	+21%	+$44.6K	﹤0.01%	569
2017 Q2	$221K	Sell	4,104 -1,202	-23%	-$64.1K	﹤0.01%	574
2017 Q1	$280K	Hold	5,306	–	–	0.01%	565
2016 Q4	$255K	Buy	5,306 +856	+19%	+$42.3K	﹤0.01%	574
2016 Q3	$240K	Sell	4,450 -440	-9%	-$24.1K	﹤0.01%	562
2016 Q2	$265K	Hold	4,890	–	–	0.01%	557
2016 Q1	$248K	Hold	4,890	–	–	0.01%	554
2015 Q4	$247K	Buy	+4,890	New	+$249K	0.01%	558

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s GSK Position: Q4 2023 in Review

Hartford Investment Management Co (HIMCO) sold out of GSK (GSK) in Q4 2023, closing a stake of 15,189 shares — an estimated $551K sold.

Hartford Investment Management Co (HIMCO) first reported a position in GSK in Q4 2015 and held it in 32 quarters. The position peaked at $607K in Q4 2021. 896 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

Hartford Investment Management Co (HIMCO) reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
Hartford Investment Management Co (HIMCO) sold 15,189 GSK shares in Q4 2023, an estimated $551K.
Hartford Investment Management Co (HIMCO) first reported a position in GSK in Q4 2015 and held it in 32 quarters.
Hartford Investment Management Co (HIMCO)'s GSK position peaked at $607K in Q4 2021.
896 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2023, filed 23 Jan 2024.